Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Tripar Multivision Plus Tbk. (RAAM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Tripar Multivision Plus Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 7.6K 24h volume), while Tripar Multivision Plus Tbk. trades at Rp188 (market cap 1.28T, 218.5K 24h volume). The key difference: Tripar Multivision Plus Tbk. is far larger — about 4× Diagnos Laboratorium Utama Tbk.'s market cap, and Tripar Multivision Plus Tbk. is more actively traded (218.5K versus 7.6K). Which is the better fit depends on your goals.
| DGNS | RAAM | |
|---|---|---|
Market Cap | 319B | 1.28T |
Volume | 7.6K | 218.5K |
Lot | 76 | 2.19K |
Turnover | 1.74M | 40.59M |
Average Price | 229.21 | 185.75 |
Value | 1.74M | 40.59M |
Indicative Equilibrium Price | 232 | 188 |
Indicative Equilibrium Volume | 200 | 12.5K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Tripar Multivision Plus Tbk.
PT Tripar Multivision Plus Tbk (“the Company”) was establishedbased on Deed of Establishment of Limited Liability Company No. 17 dated 6 December 1990 drawn up before Adlan Yulizar, S.H., notary in Jakarta.
Read more on RAAM →
